Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1803 2
1873 1
1896 1
1897 2
1900 2
1903 2
1904 2
1905 5
1908 21
1909 16
1910 16
1911 13
1912 14
1913 36
1914 16
1915 14
1916 5
1917 28
1918 3
1919 4
1920 12
1921 10
1922 1
1923 14
1924 7
1925 11
1926 12
1927 30
1928 13
1929 17
1930 20
1931 23
1932 30
1933 28
1934 13
1935 11
1936 6
1937 11
1938 12
1939 13
1940 1
1941 1
1942 2
1944 1
1945 1
1946 7
1947 12
1948 20
1949 4
1950 7
1951 3
1952 3
1953 2
1954 2
1955 3
1956 2
1957 4
1959 4
1960 1
1961 2
1962 2
1963 6
1964 6
1965 1
1966 3
1967 4
1968 7
1969 7
1970 8
1971 12
1972 8
1973 10
1974 8
1975 15
1976 13
1977 13
1978 4
1979 19
1980 8
1981 13
1982 15
1983 13
1984 6
1985 14
1986 10
1987 16
1988 10
1989 11
1990 14
1991 15
1992 12
1993 18
1994 18
1995 24
1996 18
1997 18
1998 16
1999 26
2000 27
2001 33
2002 22
2003 49
2004 42
2005 44
2006 47
2007 31
2008 39
2009 41
2010 53
2011 61
2012 41
2013 56
2014 60
2015 68
2016 58
2017 66
2018 65
2019 67
2020 85
2021 86
2022 84
2023 100
2024 13

Text availability

Article attribute

Article type

Publication date

Search Results

2,195 results

Results by year

Filters applied: . Clear all
Page 1
Recent Advances in Castleman Disease.
Hoffmann C, Hentrich M, Tiemann M, Rosenwald A, Weber F, Willenbacher W, Hübel K. Hoffmann C, et al. Among authors: weber f. Oncol Res Treat. 2022;45(11):693-704. doi: 10.1159/000526640. Epub 2022 Oct 11. Oncol Res Treat. 2022. PMID: 36219975 Review.
Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper).
Wiendl H, Gold R, Berger T, Derfuss T, Linker R, Mäurer M, Aktas O, Baum K, Berghoff M, Bittner S, Chan A, Czaplinski A, Deisenhammer F, Di Pauli F, Du Pasquier R, Enzinger C, Fertl E, Gass A, Gehring K, Gobbi C, Goebels N, Guger M, Haghikia A, Hartung HP, Heidenreich F, Hoffmann O, Kallmann B, Kleinschnitz C, Klotz L, Leussink VI, Leutmezer F, Limmroth V, Lünemann JD, Lutterotti A, Meuth SG, Meyding-Lamadé U, Platten M, Rieckmann P, Schmidt S, Tumani H, Weber F, Weber MS, Zettl UK, Ziemssen T, Zipp F; ‘Multiple Sclerosis Therapy Consensus Group’ (MSTCG). Wiendl H, et al. Among authors: weber f. Ther Adv Neurol Disord. 2021 Aug 18;14:17562864211039648. doi: 10.1177/17562864211039648. eCollection 2021. Ther Adv Neurol Disord. 2021. PMID: 34422112 Free PMC article. Review.
Integrated single-cell profiling dissects cell-state-specific enhancer landscapes of human tumor-infiltrating CD8+ T cells.
Riegel D, Romero-Fernández E, Simon M, Adenugba AR, Singer K, Mayr R, Weber F, Kleemann M, Imbusch CD, Kreutz M, Brors B, Ugele I, Werner JM, Siska PJ, Schmidl C. Riegel D, et al. Among authors: weber f. Mol Cell. 2023 Feb 16;83(4):622-636.e10. doi: 10.1016/j.molcel.2022.12.029. Epub 2023 Jan 18. Mol Cell. 2023. PMID: 36657444 Free article.
Imaging innate immunity.
Grüneboom A, Aust O, Cibir Z, Weber F, Hermann DM, Gunzer M. Grüneboom A, et al. Among authors: weber f. Immunol Rev. 2022 Mar;306(1):293-303. doi: 10.1111/imr.13048. Epub 2021 Nov 26. Immunol Rev. 2022. PMID: 34837251 Review.
Transforming growth factor-β-regulated mTOR activity preserves cellular metabolism to maintain long-term T cell responses in chronic infection.
Gabriel SS, Tsui C, Chisanga D, Weber F, Llano-León M, Gubser PM, Bartholin L, Souza-Fonseca-Guimaraes F, Huntington ND, Shi W, Utzschneider DT, Kallies A. Gabriel SS, et al. Among authors: weber f. Immunity. 2021 Aug 10;54(8):1698-1714.e5. doi: 10.1016/j.immuni.2021.06.007. Epub 2021 Jul 6. Immunity. 2021. PMID: 34233154 Free article.
[Thyroid cancer in change].
Dralle H, Weber F. Dralle H, et al. Among authors: weber f. Chirurg. 2020 Dec;91(12):991-993. doi: 10.1007/s00104-020-01290-9. Chirurg. 2020. PMID: 33263801 German. No abstract available.
Overdiagnosis is Stressful.
Freund W, Nonn T, Weber F. Freund W, et al. Among authors: weber f. Dtsch Arztebl Int. 2018 May 4;115(18):324-325. doi: 10.3238/arztebl.2018.0324c. Dtsch Arztebl Int. 2018. PMID: 29807564 Free PMC article. No abstract available.
Fibroblast Activation Protein α-Targeted CD40 Agonism Abrogates Systemic Toxicity and Enables Administration of High Doses to Induce Effective Antitumor Immunity.
Sum E, Rapp M, Fröbel P, Le Clech M, Dürr H, Giusti AM, Perro M, Speziale D, Kunz L, Menietti E, Brünker P, Hopfer U, Lechmann M, Sobieniecki A, Appelt B, Adelfio R, Nicolini V, Freimoser-Grundschober A, Jordaan W, Labiano S, Weber F, Emrich T, Christen F, Essig B, Romero P, Trumpfheller C, Umaña P. Sum E, et al. Among authors: weber f. Clin Cancer Res. 2021 Jul 15;27(14):4036-4053. doi: 10.1158/1078-0432.CCR-20-4001. Epub 2021 Mar 26. Clin Cancer Res. 2021. PMID: 33771854
2,195 results